Skip to main content

Read more
Governance Annual Snapshot Reconciliation Action Plan Disability Access and Inclusion Plan Diversity and Inclusion Action Plan Professional Accountability Program Research Services Office Researchers and sponsors Research participants Clinical trials Grants and funding News and events Clinical Strategy Strategic Ambition Consumer Strategy Aboriginal Employment Strategy Research Strategy Concerns about your care Informed consent Consumer experience Consumer partnering Compliments and complaints Your rights and responsibilities Aboriginal and Torres Strait Islander Health Community snapshot
Careers News Contact us
Governance Annual Snapshot Reconciliation Action Plan Disability Access and Inclusion Plan Diversity and Inclusion Action Plan Professional Accountability Program Research Services Office Researchers and sponsors Research participants Clinical trials Grants and funding News and events Clinical Strategy Strategic Ambition Consumer Strategy Aboriginal Employment Strategy Research Strategy Concerns about your care Informed consent Consumer experience Consumer partnering Compliments and complaints Your rights and responsibilities Aboriginal and Torres Strait Islander Health Community snapshot

Our partnerships

Collaboration is key in CALHN’s vision to be a global leader in healthcare research. Learn about CALHN’s valued partners in South Australia and beyond.

Our partnerships allow us to bring together the very best in research, clinical care and infrastructure to improve healthcare delivery and outcomes for the communities of Adelaide, Australia and the world. Click on each partner to learn more.

Adelaide BioMed City is a city precinct designed for medical research collaboration to accelerate health innovation and transformative research.

Incorporating the Royal Adelaide Hospital, the precinct will assist CALHN to translate research into best practice models of care for our patients and the community.

The South Australian Health and Medical Research Institute (SAHMRI) promotes research collaborations to optimise health outcomes and improve health equity.

The Centre for Cancer Biology is one of Australia’s peak cancer medical research institutes and houses the largest concentration of cancer research in South Australia.

Supported by SA Pathology and the University of South Australia, it carries out a world-class program making breakthrough discoveries in the fundamental causes of cancer, and translating these discoveries into new ways to prevent and treat this group of diseases.

The Basil Hetzel Institute for Translational Health Research (BHI) is the productive research arm of CALHN’s The Queen Elizabeth Hospital (TQEH).

BHI research groups have strong links to clinical divisions within TQEH, underpinning translational health research to improve public health and deliver innovations in patient care.

CALHN’s partnership with the University Health Network, a world-leading health and medical research organisation, will help investigate the causes of numerous diseases and develop new ways to treat them.

Our collaboration with UHN researchers will also offer access to cutting-edge technologies and support our research innovation programs.

Every day CALHN researchers make important scientific discoveries and breakthroughs to deliver enhanced health outcomes for our community.

Health Translation SA brings together a diverse network, including researchers, clinicians and consumers, to develop resources to advance healthcare systems the wellbeing of South Australians.

SA ImmunoGenomics Cancer Institute (SAiGENCI) is South Australia’s world-class cancer research institute focusing on cancer research and clinical trials, supported by CALHN and the University of Adelaide.

CALHN’s involvement as an alliance partner in SAiGENCI will lead to improved treatment and care options for South Australians living with cancer.

CALHN research structure infographic including biomed city information.

This page was last updated 27 May 2025.

Back to top